 WALTHAM, Mass., May 28, 2021 GLOBE NEWSWIRE -- Morphic Therapeutic Nasdaq: MORF, a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that members of the Morphic leadership team are scheduled to present at the Jefferies Virtual Healthcare Conference on June 4, 2021 at 9:00 AM ET. 